Investigational research peptide

BPC-157

Synthetic 15-residue gastric peptide studied in preclinical tissue-response models.

Explore presentation-specific analytical records covering identity, purity, measured content, lot traceability and downloadable Certificates of Analysis.

Certified presentations
Product information
Royal Pharma BPC-157 vial
Selected record10 mg

Product-family image supplied by Royal Pharma. Certified presentations are identified by their individual COA records below.

Product authentication

Authenticity, built into every product.

Powered by NFC. Secured by blockchain. Verified instantly.

Each Royal Pharma product carries a unique NFC-enabled microchip connected to the brand's proprietary blockchain authentication environment, creating a secure, traceable and tamper-resistant digital identity.

01
Unique identity

A product-linked NFC identity designed for one-tap verification.

02
Secure verification

A blockchain-secured record supporting authenticity and traceability.

03
Batch documentation

Presentation-specific COAs document identity, purity, measured content and lot information.

Product information

A gastric peptide model, documented by batch.

BPC-157 is a synthetic 15-amino-acid peptide used in laboratory models examining tissue response, cell migration and vascular signalling. This page pairs its research classification with presentation-specific Royal Pharma analytical records.

01

Research class

Synthetic 15-residue gastric peptide
02

Documentation status

Preclinical research compound
03

Reference CAS

137525-51-0
04

Physical form

White lyophilised powder

Research profile

One short sequence. Multiple research endpoints.

Preclinical literature examines BPC-157 across connective-tissue, endothelial and barrier models. These observations remain experimental and are presented here only as research context.

15 AA
Cell migration models

Laboratory work examines fibroblast outgrowth and migration under controlled conditions.

VEGFR2
Vascular signalling

Preclinical studies describe VEGFR2-associated signalling and endothelial model endpoints.

MATRIX
Barrier research

Gastric and intestinal tissue models form part of the compound's original research base.

Quality documentation

Certificate of Analysis

Choose a presentation to display the exact analytical record
supplied for that sample.

Select presentation
Selected COA

BPC-157 · 10 mg

Purity99%
Measured content
10.14 mg
Identity
BPC-157
Lot
N/A
Appearance
White Lyophilized Powder
Accession number
2602020210
Search code
Received
02/08/2026
Reported
2/10/2026
For laboratory research use only.

The supplied certificates state that the tested materials are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications. Results are specific to the submitted samples. This page does not provide medical advice, dosing or administration instructions.